Cargando…
Enhanced expression of vascular endothelial growth factor in metastatic melanoma.
Tumour growth is dependent on angiogenesis. Vascular endothelial growth factor (VEGF) is a secreted endothelial cell-specific cytokine. VEGF is angiogenic in vivo and it also acts as a vascular permeability factor. VEGF is overexpressed in many skin disorders characterized by angiogenesis and increa...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228068/ https://www.ncbi.nlm.nih.gov/pubmed/9328154 |
_version_ | 1782149828523851776 |
---|---|
author | Salven, P. Heikkilä, P. Joensuu, H. |
author_facet | Salven, P. Heikkilä, P. Joensuu, H. |
author_sort | Salven, P. |
collection | PubMed |
description | Tumour growth is dependent on angiogenesis. Vascular endothelial growth factor (VEGF) is a secreted endothelial cell-specific cytokine. VEGF is angiogenic in vivo and it also acts as a vascular permeability factor. VEGF is overexpressed in many skin disorders characterized by angiogenesis and increased vascular permeability. We investigated VEGF expression in 22 primary cutaneous melanomas, 33 melanoma metastases and six naevocellular naevi using immunohistochemistry. VEGF accumulated on the vascular endothelia in the normal dermis, suggesting that a constitutive low level of VEGF expression may regulate skin vessel function under normal physiological conditions. No VEGF was detected in the cells of naevocellular naevi or normal dermis. In contrast, 32% of the primary and 91% of the metastatic melanomas contained melanoma cells staining for VEGF. Expression of VEGF was more frequent in metastases than in primary melanomas (P <0.0001). Tumour-infiltrating inflammatory cells expressed VEGF in all melanomas. A high number of VEGF-expressing inflammatory cells was associated with high VEGF expression in melanoma cells (P = 0.003). Our results suggest that VEGF is up-regulated during the course of melanoma progression and dissemination and that tumour-infiltrating cells expressing VEGF may contribute to the progression of melanoma. IMAGES: |
format | Text |
id | pubmed-2228068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-22280682009-09-10 Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Salven, P. Heikkilä, P. Joensuu, H. Br J Cancer Research Article Tumour growth is dependent on angiogenesis. Vascular endothelial growth factor (VEGF) is a secreted endothelial cell-specific cytokine. VEGF is angiogenic in vivo and it also acts as a vascular permeability factor. VEGF is overexpressed in many skin disorders characterized by angiogenesis and increased vascular permeability. We investigated VEGF expression in 22 primary cutaneous melanomas, 33 melanoma metastases and six naevocellular naevi using immunohistochemistry. VEGF accumulated on the vascular endothelia in the normal dermis, suggesting that a constitutive low level of VEGF expression may regulate skin vessel function under normal physiological conditions. No VEGF was detected in the cells of naevocellular naevi or normal dermis. In contrast, 32% of the primary and 91% of the metastatic melanomas contained melanoma cells staining for VEGF. Expression of VEGF was more frequent in metastases than in primary melanomas (P <0.0001). Tumour-infiltrating inflammatory cells expressed VEGF in all melanomas. A high number of VEGF-expressing inflammatory cells was associated with high VEGF expression in melanoma cells (P = 0.003). Our results suggest that VEGF is up-regulated during the course of melanoma progression and dissemination and that tumour-infiltrating cells expressing VEGF may contribute to the progression of melanoma. IMAGES: Nature Publishing Group 1997 /pmc/articles/PMC2228068/ /pubmed/9328154 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Salven, P. Heikkilä, P. Joensuu, H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. |
title | Enhanced expression of vascular endothelial growth factor in metastatic melanoma. |
title_full | Enhanced expression of vascular endothelial growth factor in metastatic melanoma. |
title_fullStr | Enhanced expression of vascular endothelial growth factor in metastatic melanoma. |
title_full_unstemmed | Enhanced expression of vascular endothelial growth factor in metastatic melanoma. |
title_short | Enhanced expression of vascular endothelial growth factor in metastatic melanoma. |
title_sort | enhanced expression of vascular endothelial growth factor in metastatic melanoma. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228068/ https://www.ncbi.nlm.nih.gov/pubmed/9328154 |
work_keys_str_mv | AT salvenp enhancedexpressionofvascularendothelialgrowthfactorinmetastaticmelanoma AT heikkilap enhancedexpressionofvascularendothelialgrowthfactorinmetastaticmelanoma AT joensuuh enhancedexpressionofvascularendothelialgrowthfactorinmetastaticmelanoma |